Improved diagnosis of pancreatic adenocarcinoma using haptoglobin and serum amyloid a in a panel screen

World Journal of Surgery

Volumn 33, Issue 4, 2009, Pages 716-722

  Firpo, Matthew A ^a   Gay, David Z ^a   Granger, Steven R ^a   Scaife, Courtney L ^a,b   DiSario, James A ^a,b   Boucher, Kenneth M ^a,b   Mulvihill, Sean J ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN; HAPTOGLOBIN; SERUM AMYLOID A;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER SCREENING; CHRONIC PANCREATITIS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PROTEIN BLOOD LEVEL;

ADENOCARCINOMA; ALGORITHMS; CA-19-9 ANTIGEN; FEMALE; HAPTOGLOBINS; HUMANS; MALE; PANCREATIC NEOPLASMS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SERUM AMYLOID A PROTEIN; TUMOR MARKERS, BIOLOGICAL;

EID: 62549122472     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-008-9853-9     Document Type: Article

References (38)

1. A Jemal R Siegel E Ward 2008 Cancer statistics, 2008 CA Cancer J Clin 58 71 96
2. J Glenn WM Steinberg SH Kurtzman 1988 Evaluation of the utility of a radioimmunoassay for serum CA 19-9 levels in patients before and after treatment of carcinoma of the pancreas J Clin Oncol 6 462 468
3. RE Ritts HA Pitt 1998 CA 19-9 in pancreatic cancer Surg Oncol Clin N Am 7 93 101
4. KS Goonetilleke AK Siriwardena 2007 Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer Eur J Surg Oncol 33 266 270
5. A Cooperman 2001 The pancreas revisited. II. Benign and malignanat tumors-an interdisciplinary approach: pancreatic cancer Surg Clin 81 3
6. R Peterli B Meyer-Wyss U Herzog 1999 CA19-9 has no value as a tumor marker in obstructive jaundice Schweiz Med Wochenschr 129 77 79
7. DV Gold DE Modrak Z Ying 2006 New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis J Clin Oncol 24 252 258
8. T Grote CD Logsdon 2007 Progress on molecular markers of pancreatic cancer Curr Opin Gastroenterol 23 508 514
9. M Ibis S Koklu FM Yilmaz 2007 Serum adenosine deaminase levels in pancreatic diseases Pancreatology 7 526 530
10. J Koopmann NS Fedarko A Jain 2004 Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma Cancer Epidemiol Biomarkers Prev 13 487 491
11. J Koopmann CN Rosenzweig Z Zhang 2006 Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9 Clin Cancer Res 12 442 446
12. KF Kuhlmann JW van Till MA Boermeester 2007 Evaluation of matrix metalloproteinase 7 in plasma and pancreatic juice as a biomarker for pancreatic cancer Cancer Epidemiol Biomarkers Prev 16 886 891
13. C Melle G Ernst N Escher 2007 Protein profiling of microdissected pancreas carcinoma and identification of HSP27 as a potential serum marker Clin Chem 53 629 635
14. C Rosty L Christa S Kuzdzal 2002 Identification of hepatocarcinoma- intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology Cancer Res 62 1868 1875
15. DM Simeone B Ji M Banerjee 2007 CEACAM1, a novel serum biomarker for pancreatic cancer Pancreas 34 436 443
16. W Zhou LJ Sokoll DJ Bruzek 1998 Identifying markers for pancreatic cancer by gene expression analysis Cancer Epidemiol Biomarkers Prev 7 109 112
17. A Bharti PC Ma G Maulik 2004 Haptoglobin alpha-subunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in small cell lung cancer Anticancer Res 24 1031 1038
18. H Biran N Friedman L Neumann 1986 Serum amyloid A (SAA) variations in patients with cancer: correlation with disease activity, stage, primary site, and prognosis J Clin Pathol 39 794 797
19. DC Chan CJ Chen HC Chu 2007 Evaluation of serum amyloid A as a biomarker for gastric cancer Ann Surg Oncol 14 84 93
20. EP Diamandis 2004 Identification of serum amyloid A protein as a potentially useful biomarker for nasopharyngeal carcinoma [letter]. Clin Cancer Res 10:5293. Reply Clin Cancer Res 10 5293 5294
21. I Glojnaric MT Casl D Simic 2001 Serum amyloid A protein (SAA) in colorectal carcinoma Clin Chem Lab Med 39 129 133
22. BA Howard MZ Wang MJ Campa 2003 Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization-time of flight spectra analysis Proteomics 3 1720 1724
23. N Khan CJ Cromer M Campa 2004 Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma Cancer 101 379 384
24. J Tolson R Bogumil E Brunst 2004 Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients Lab Invest 84 845 856
25. B Ye DW Cramer SJ Skates 2003 Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry Clin Cancer Res 9 2904 2911
26. R Deng Z Lu Y Chen 2007 Plasma proteomic analysis of pancreatic cancer by 2-dimensional gel electrophoresis Pancreas 34 310 317
27. JM Koomen LN Shih KR Coombes 2005 Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins Clin Cancer Res 11 1110 1118
28. ZL Sun Y Zhu FQ Wang 2007 Serum proteomic-based analysis of pancreatic carcinoma for the identification of potential cancer biomarkers Biochim Biophys Acta 1774 764 771
29. K Yokoi LC Shih R Kobayashi 2005 Serum amyloid A as a tumor marker in sera of nude mice with orthotopic human pancreatic cancer and in plasma of patients with pancreatic cancer Int J Oncol 27 1361 1369
30. W Dobryszycka 1997 Biological functions of haptoglobin-new pieces to an old puzzle Eur J Clin Chem Clin Biochem 35 647 654
31. S Oshiro Y Yajima K Kawamura 1992 Catabolism of hemoglobin-haptoglobin complex in microsome subfractions Chem Pharm Bull (Tokyo) 40 1847 1851
32. MC Cid DS Grant GS Hoffman 1993 Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis J Clin Invest 91 977 985
33. JM Gutteridge 1987 The antioxidant activity of haptoglobin towards haemoglobin-stimulated lipid peroxidation Biochim Biophys Acta 917 219 223
34. DP De Kleijn MB Smeets PP Kemmeren 2002 Acute-phase protein haptoglobin is a cell migration factor involved in arterial restructuring FASEB J 16 1123 1125
35. CM Uhlar AS Whitehead 1999 Serum amyloid A, the major vertebrate acute-phase reactant Eur J Biochem 265 501 523
36. Y Kaneta Y Kagami T Tsunoda 2003 Genome-wide analysis of gene-expression profiles in chronic myeloid leukemia cells using a cDNA microarray Int J Oncol 23 681 691
37. A Nishie K Masuda M Otsubo 2001 High expression of the Cap43 gene in infiltrating macrophages of human renal cell carcinomas Clin Cancer Res 7 2145 2151
38. MB Smeets J Fontijn A Kavelaars 2003 The acute phase protein haptoglobin is locally expressed in arthritic and oncological tissues Int J Exp Pathol 84 69 74